VENTMICS: The Effect of Mechanical Ventilation on the Occurrence of Myocardial Ischemia: a Pilot Study

Sponsor
Jessa Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05109715
Collaborator
(none)
10
1
2
7.2
1.4

Study Details

Study Description

Brief Summary

The goal of the proposed pilot study is to determine which method can detect myocardial ischemia at the predefined timepoints during endo-CABG. Additionally, the investigators want to examine the influence of mechanical ventilation on the occurrence of myocardial ischemia in patients undergoing endo-CABG.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Continued ventilation
  • Procedure: Discontinued ventilation
N/A

Detailed Description

CABG is the most effective therapy for patients suffering from coronary artery disease, a condition which annually affects 126 million people worldwide. During this surgery, cardiopulmonary bypass (CPB) takes over the function of the heart and lungs. As a result of the emergence of minimally invasive cardiac surgery (MICS) (e.g. endoscopic-CABG), peripheral CPB with femoral arterial cannulation became the most commonly utilized strategy. However, the use of retrograde arterial perfusion is not without risk. It may result in the upper body and coronary arteries being perfused with deoxygenated blood. The hypoxemia will induce myocardial ischemia and this can harm the cardiac myocytes. A solution for this inconvenience is still lacking. Literature reports that establishing adequate ventilation support should help overcome this phenomenon. However, this approach has not yet been investigated in a clinical trial. In general, this phenomenon is not well recognized in the typical surgical setting, and limited research has been done.

The goal of the proposed pilot study is to determine which method can detect myocardial ischemia at the predefined timepoints during endo-CABG. Additionally, the investigators want to examine the influence of mechanical ventilation on the occurrence of myocardial ischemia in patients undergoing endo-CABG.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Mechanical Ventilation on the Occurrence of Myocardial Ischemia in Patients Undergoing Endoscopic Coronary Artery Bypass Grafting (Endo-CABG): a Pilot Study
Actual Study Start Date :
Jan 24, 2022
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control group

Ventilation is discontinued after going on CPB and lungs are exposed to atmospheric pressure. Blood will be drawn: At baseline: before general anaesthesia After start of heart-lung machine After clamping the aorta Before unclamping the aorta After the operation 5 h after clamping the aorta 12 hours after clamping the aorta 24 hours after aortic clamping 48h after clamping the aorta 72 hours after clamping the aorta

Procedure: Discontinued ventilation
Ventilation is discontinued after going on CPB and lungs are exposed to atmospheric pressure

Experimental: Ventilation group

Ventilation is continued from going on CPB until clamping of the ascending aorta. Blood will be drawn: At baseline: before general anaesthesia After start of heart-lung machine After clamping the aorta Before unclamping the aorta After the operation 5 h after clamping the aorta 12 hours after clamping the aorta 24 hours after aortic clamping 48h after clamping the aorta 72 hours after clamping the aorta

Procedure: Continued ventilation
Ventilation is continued from going on CPB until clamping of the ascending aorta with tidal volume 3ml/kg ideal body weight, Fraction of inspired oxygen (FiO2) 50%, respiratory rate 5/min and Inspiratory:Expiratory (I/E) ratio 1/2.

Outcome Measures

Primary Outcome Measures

  1. The detection of myocardial ischemia using Cardiac Troponin T (cTn-T) [Until 72 hours after clamping the aorta]

    If the value of Cardiac Troponin T (cTn-T) exceeds 14 ng/L, then cTn-T is able to detect myocardial ischemia at the predefined time points.

  2. The detection of myocardial ischemia using Heart-type Fatty Acid Binding Protein (hFABP) [Until 5 hours after clamping the aorta]

    If the value of Heart-type Fatty Acid Binding Protein (hFABP) exceeds 6 ng/L, then hFABP is able to detect myocardial ischemia at the predefined time points.

  3. The detection of myocardial ischemia using Creatine Kinase Myocardial Band (CK-MB) [Until 48 hours after clamping the aorta]

    If the value of Creatine Kinase Myocardial Band (CK-MB) exceeds 6.2 µg/L, then CK-MB is able to detect myocardial ischemia at the predefined time points.

  4. The detection of myocardial ischemia using Reactive Oxygen Species (ROS) [Until unclamping the aorta (on average until 64 minutes after clamping the aorta)]

    Reactive Oxygen Species (ROS) measurements include a malondialdehyde assay to assess the lipid peroxidation, an Oxystat test to analyse the total peroxide levels and a protein carbonyl assay to assess the protein damage due to cardiomyocyte dysfunction. Additionally a biopsy will be taken to analyze pro- and anti-oxidants. If a significant increase in lipid peroxidation, total peroxide levels, protein damage and/or pro- and anti-oxidants in the ventilation group compared to the control group is present, then ROS is able to detect myocardial ischemia at the predefined time points.

  5. The occurence of hypoxemia using blood gas measurement [Until the end of surgery (on average until 203 minutes after the start of the surgery)]

    If the partial pressure of oxygen (PaO2) is lower than 60 mmHg, then hypoxemia is present.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 years old

  • Patients undergoing their first elective endo-CABG procedure

  • Patients capable of signing the informed consent

  • Patients able to speak Dutch or French

Exclusion Criteria:
  • Ongoing participation in another trial

  • Ejection fraction < 50%

  • Lung diseases (COPD, asthma)

  • Use of corticosteroids

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jessa Hospital Hasselt Limburg Belgium

Sponsors and Collaborators

  • Jessa Hospital

Investigators

  • Principal Investigator: Abdullah Kaya, PhD, Jessa Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jessa Hospital
ClinicalTrials.gov Identifier:
NCT05109715
Other Study ID Numbers:
  • f/2021/118
First Posted:
Nov 5, 2021
Last Update Posted:
Feb 11, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Jessa Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 11, 2022